Search Cancer Clinical Trials

Mass General Brigham Cancer Institute offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
16 results
  • Prostate Cancer

25-737          Phase II

A Phase II, randomized, open-label, multi-center study of JSB462 (luxdegalutamide) in combination with lutetium (177Lu) vipivotide tetraxetan in adult male patients with PSMA-positive metastatic castration resistant prostate cancer (mCRPC)

  • Prostate Cancer

08-207          N/A

Circulating Tumor Cell Analysis in Patients with Localized Prostate Cancer Undergoing Prostatectomy

  • Bladder Cancer, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Gastric (Stomach) Cancer, Head and Neck Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer

25-624          Phase I

First-in-Human, Phase 1 Study of ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors

  • Esophageal Cancer, Breast Cancer, Cervical Cancer, Endometrial Cancer, Prostate Cancer, Gastric (Stomach) Cancer, Head and Neck Cancer, Lung Cancer, Ovarian Cancer

25-892          Phase I

Phase 1, First-in-Human, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Patients with Advanced Solid Tumors

  • Prostate Cancer

25-374          Phase II

Phase 1/2 Study of HLD-0915 in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)

  • Prostate Cancer

25-864          Phase I

TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Showing 1 - 10 of 16 results